Pharmaceutical Technology on MSN
Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal
MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (EYEN) (NASDAQ: EYEN), an ophthalmic technology company developing the Optejet ® device for use both in connection with its own drug-device ...
NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Eyenovia (EYEN), Inc. , an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ophthalmic ...
Blue Fin Vision and Zeiss Medical Technology have announced their partnership on a new series of international presentations by Mr Mfazo Hove.
November 14, 2025 -- Heidelberg Engineering today announced that it is joining the Collaborative Community on Ophthalmic Innovation (CCOI) as part of its parent company EssilorLuxottica's Vision ...
Eyenovia announces progress on its user-filled Optejet eye drop dispenser, aiming for U.S. regulatory approval in late 2025. Eyenovia, Inc. has made significant advancements in the development of its ...
Request To Download Free Sample of This Strategic Report @ Dominance of Cataract Surgery Devices: The cataract surgery devices segment has emerged as the frontrunner in the ophthalmic surgical ...
2023 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Current study results on Information Technology have been published. According to news reporting from ...
Ophthalmic Consultants of Boston is a referral center for advanced eye care, serving patients throughout Greater Boston, Metrowest, the North Shore, South Shore and Cape Cod. It was the first private ...
2022 FEB 08 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Business Daily-- Investigators publish new report on Information Technology. According to news originating from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results